Despite expression of surface death receptors, including TNF-R1, Fas and TRAIL-R1 and R2, cells from a significant proportion of ALL patients are resistant to ligand-induced apoptosis when exposed to TNF-α, FasL or TRAIL [10]–[12]. Here, TNFRSF1A is linked to acute lymphoblastic leukemia.